That's good to know, EB, I asked Dr, Natale if and Atriclip would be a better option for me than Lariet-II, if they had a minimally invasive method of installing it as I liked the look of the Articlip when exploring it on their website. However he said Atriclip requires a significantly more invasive procedure ... ala a mini-maze/5Box or even open chest cardiac operation for which the Articlip was originally intended ... to be in position to install it than does the truly minimally invasive Lariet-II. However, both devices are similar in overall design and are trying to accomplish the same thing with a similar method by sealing off the LAA from the outside at the very hilt of the LAA where the LAA joins the wall of the left atrium.
The one other issue he brought up with the Atricure that makes him prefer the Lariet-II is that apparently by using a transeptal catheter balloon that is first placed inside the LAA endocardially and then expanded, it better delineates the true 'flush' level where the LAA opening joins the outside of the LA and also defines better where the inside opening of the LAA is within the Interior of the LA. That plus the relatively thinner double loop pre-tied stitch apparently allows the cardiac surgeon working with the EP in this combined endocardial/ epicardial procedure to snug that thinner stick down even closer to the hilt and thus more often get a more flush seal when viewed from the inside of the LAA where the ostium or mouth of the LAA opens up into the LA.
What you want ideally is as smooth a seal as possible with little to no remaining 'divit' or depression remaining where the mouth of the LAA used to open up into the actual LAA interior volume, as any depression or pocket-like depression from not having a very close and flush seal there can still allow the kind of 'A-wave' doppler inflow characteristics at the mitral inflow when seen on follow-up TEE that still makes possible the formation of Spontaneous Echo Contrasts (SEC) or frank clots to still form and not necessarily allow safe stopping of anti-coagulation in some cases.
Thats at least how I understand his point and he said that Lariet-II made it easier and more reliable to acheive said Flush seal between the inner opening of the LAA and the LA itself. That is why they are seeing a greater than 95% success rate in stopping Coumadin or other blood thinner after successful Lariet-II installation so far, and as doctor experience increases that overall very high rate is sure to climb he feels.
However, since Dr Sirac was already in there with his moderately less invasive procedure, certainly far less invasive than a full open chest heart/lung bypass, it makes perfect sense to use the Atriclip which is no doubt the best option once you are already inside the pericardial sack and have some visual access and confirmation for placement as well.
I like the special soft fabric contact surface on the Atriclip, but can also see where the nature of the clip and relative thickness of of the clip 'arms' itself can make it tricky when clipped over the outside hilt of the LAA to get a very flush seal on the inside of the LAA/LA junction compared to the much thinner nature of the pre-tied suture system that is the Lariet-II system that makes it easier to acheive a finer flush seal in experienced hands.
Anyway, the main thing for both systems is a good fit and then real life long protection should be the major reward! The good news too once either the Atriclip or Lariet-II is installed properly is that even if you should ever have another episode of AFIB or Flutter, your chances of a stroke forming clot are not any greater really than f or the average person at your age and CHADs 2 score in NSR! So the anti-coagualtion issue can truly become a concern of the past!
Here is a link to the Atriclip system:
Atriclip LAA Exclusion system
And the Lariet-II device and system:
Lariet-II study and video example of implantation
Dr. Natale and his partner Dr, Burkhardt have together installed almost 50 Lariet-II LAAC suture devices so far and more all teh time so out of the approximately 400+ cases since it was first introduced in 2009 they have done a large percentage of teh total cases for a single EP/team giving them a solid experience head start.
In most of these LAAC methods that include an endocardial transeptal step as part of the procedure, having an EP who is vastly experienced in transeptal puncture is a good insurance against one possible source of unwanted complication from the procedure. Otherwise, the Lariet-II seems to be a relatively safe with a good deal less serious complications than either the Watchman (which is supposedly improved with the latest generation) or the Amplatzer as well as those with surgical ligation and removal of the LAA with the added bleeding risk.
In any event, for anyone that requires life long anti-coagulation paying close attention to these new devices and the collective experience with multiple centers and EPs is a very good idea that could well eliminate the entire anti-coagulation risk without any blood thinning drugs at all!
Shannon